The major objective of the, Duke Skin Disease Research Core Center (Duke SDRC) is to provide SDRC members and others access to the technologies and resources needed to facilitate biological studies at the gene, cellular, tissue, and animal levels. The Administrative Core will be responsible for oversight of the core services and overall center operations. Dr. Russell Hall will have primary responsibility for supervising and coordinating the day to day operations of the SDRC. He will be assisted by the Associate Director, the SDRC administrator, and the leaders of the Research Cores. The governance of the SDRC will be provided by an Executive Committee consisting of the Director, Associate Director, Research Core Directors, and the Director of the Enrichment Program; input will be obtained quarterly from an internal advisory committee on scientific direction, optimal integration of the Center with existing institutional resources, adequacy and quality of performance in the Research Cores, and overall vision for the Center. The members of the Advisory Committee will be chosen based on their credentials as researchers, specific content expertise for one or more of the Cores, and demonstrated success in leadership programs aimed at translating basic discoveries into clinical practice.
The Specific Aims of the Administrative Core are the following: (1) Provide oversight of the Center's operations, performance, and utilization, including re-allocation of resources as appropriate. (2) Define and implement application process for Center membership based on investigator eligibility, scientific excellence, and relevance to skin biology and/or skin diseases. (3) Assess ongoing suitability and utilization of core services and implement changes as dictated by new technology, demands for new services, economic factors, and/or outcomes. (4) Provide communication infrastructure and promote collaboration between investigators and core to optimize the Center's impact.

Public Health Relevance

The Administrative Core will provide direction and oversight to all elements of the SDRC. This core will ensure that all research cores are providing services appropriately; that the enrichment program is attracting new investigators and enhancing the productivity of all members; that SDRC resources are allocated in a productive and transparent fashion; and that services and progress are evaluated effectively.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAR1-KM (M1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
United States
Zip Code
Jin, Yingai Jane; Wang, Sally; Cho, Joshua et al. (2016) Epidermal CYLD inactivation sensitizes mice to the development of sebaceous and basaloid skin tumors. JCI Insight 1:
Thakore, Pratiksha I; Gersbach, Charles A (2016) Design, Assembly, and Characterization of TALE-Based Transcriptional Activators and Repressors. Methods Mol Biol 1338:71-88
Liu, Xinjian; Zhou, Min; Mei, Ling et al. (2016) Key roles of necroptotic factors in promoting tumor growth. Oncotarget 7:22219-33
Thakore, Pratiksha I; Black, Joshua B; Hilton, Isaac B et al. (2016) Editing the epigenome: technologies for programmable transcription and epigenetic modulation. Nat Methods 13:127-37
Chen, Yong; Fang, Quan; Wang, Zilong et al. (2016) Transient Receptor Potential Vanilloid 4 Ion Channel Functions as a Pruriceptor in Epidermal Keratinocytes to Evoke Histaminergic Itch. J Biol Chem 291:10252-62
Ousterout, David G; Gersbach, Charles A (2016) The Development of TALE Nucleases for Biotechnology. Methods Mol Biol 1338:27-42
Black, Joshua B; Adler, Andrew F; Wang, Hong-Gang et al. (2016) Targeted Epigenetic Remodeling of Endogenous Loci by CRISPR/Cas9-Based Transcriptional Activators Directly Converts Fibroblasts to Neuronal Cells. Cell Stem Cell 19:406-14
Li, Fang; Liu, Xinjian; Sampson, John H et al. (2016) Rapid Reprogramming of Primary Human Astrocytes into Potent Tumor-Initiating Cells with Defined Genetic Factors. Cancer Res 76:5143-50
Hilton, Isaac B; D'Ippolito, Anthony M; Vockley, Christopher M et al. (2015) Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol 33:510-7
Polstein, Lauren R; Perez-Pinera, Pablo; Kocak, D Dewran et al. (2015) Genome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activators. Genome Res 25:1158-69

Showing the most recent 10 out of 18 publications